Navigation Links
InSet Technologies Appoints Jon Tremmel to its Board of Directors

MT. OLIVE, N.J., May 9 /PRNewswire/ -- InSet Technologies, an emerging leader in the development of implantable drug infusion pumps for targeted delivery of medications, announced today the addition of Jon Tremmel to its Board of Directors.

Before retiring from Medtronic Inc. after nearly 30 years of service, Jon held a number of senior leadership positions including President of the Neurological Division, President of the Physio-Control Division, President of the Tachyarrhythmia Management Division and President of the Interventional Vascular Division.

"InSet Technologies has a very innovative product in clinical trials right now, and I look forward to being part of this growing company," said Jon Tremmel. "I have spent most of my career seeking technological solutions to help patients manage chronic conditions. None is more important to me than finding more effective methods to manage the debilitating conditions of chronic pain."

Mr. Tremmel also has served as a key member of the Medtronic Senior Management Operating Committee. He achieved a Masters Degree in Engineering from Boston University and a MBA from the University of Minnesota. Jon presently resides in Minneapolis, Minnesota, with his family and is an active member of the Minnesota Zoo Board, in addition to various Board positions for other companies.

"InSet has made substantial progress in the development of a new generation of implantable drug infusion pump technologies. Jon brings a wealth of business expertise that will contribute to our growth and enhance value to our shareholders," said Steve Adler, President and CEO of Inset Technologies. "We look forward to his contribution to our company at this important time in our history."

About InSet

InSet Technologies Incorporated ( headquartered in Mt. Olive, NJ is a development-stage medical device company. Its first product, the Prometra(R) programmable, implantable drug infusion pump is undergoing clinical trials for the treatment of chronic pain. About 70 million people in the United States live with chronic pain. Chronic pain costs the U.S. more in lost productivity and treatment than heart disease and cancer combined.

CAUTION: Prometra(R) pumps are Investigational Devices, which have not yet been approved by the FDA.

SOURCE InSet Technologies
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
2. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
3. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
4. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
5. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
6. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
7. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
8. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
9. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
10. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
11. DNA Sequencing Equipment Market to Fragment and Grow as Competition, New Technologies Develop
Post Your Comments:
(Date:6/23/2016)... 23, 2016 Houston Methodist Willowbrook Hospital ... Sports Association to serve as their official health ... Methodist Willowbrook will provide sponsorship support, athletic training ... association coaches, volunteers, athletes and families. ... Sports Association and to bring Houston Methodist quality ...
(Date:6/23/2016)...  The Prostate Cancer Foundation (PCF) is pleased to announce 24 ... for prostate cancer. Members of the Class of 2016 were selected from a ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)...   EpiBiome , a precision microbiome engineering company, ... financing from Silicon Valley Bank (SVB). The financing will ... its drug development efforts, as well as purchase additional ... has been an incredible strategic partner to us – ... would provide," said Dr. Aeron Tynes Hammack , ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample ... the Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. ... said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our capacity ...
Breaking Biology Technology:
(Date:6/21/2016)... Columbia , June 21, 2016 ... to the new role of principal product architect ... named the director of customer development. Both will ... chief technical officer. The moves reflect NuData,s strategic ... in response to high customer demand and customer ...
(Date:6/16/2016)... 2016 The global ... reach USD 1.83 billion by 2024, according to ... Technological proliferation and increasing demand in commercial buildings, ... drive the market growth.      (Logo: ... development of advanced multimodal techniques for biometric authentication ...
(Date:6/9/2016)... attendance control systems is proud to announce the introduction of fingerprint attendance control software, ... employees are actually signing in, and to even control the opening of doors. ... ... ... Photo - ...
Breaking Biology News(10 mins):